1. Home
  2. FGEN vs XBP Comparison

FGEN vs XBP Comparison

Compare FGEN & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • XBP
  • Stock Information
  • Founded
  • FGEN 1993
  • XBP 2020
  • Country
  • FGEN United States
  • XBP United States
  • Employees
  • FGEN N/A
  • XBP N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • XBP Business Services
  • Sector
  • FGEN Health Care
  • XBP Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • XBP Nasdaq
  • Market Cap
  • FGEN 38.4M
  • XBP 71.0M
  • IPO Year
  • FGEN 2014
  • XBP N/A
  • Fundamental
  • Price
  • FGEN $11.84
  • XBP $0.98
  • Analyst Decision
  • FGEN Strong Buy
  • XBP
  • Analyst Count
  • FGEN 2
  • XBP 0
  • Target Price
  • FGEN $146.50
  • XBP N/A
  • AVG Volume (30 Days)
  • FGEN 51.6K
  • XBP 502.8K
  • Earning Date
  • FGEN 11-11-2025
  • XBP 11-11-2025
  • Dividend Yield
  • FGEN N/A
  • XBP N/A
  • EPS Growth
  • FGEN N/A
  • XBP N/A
  • EPS
  • FGEN N/A
  • XBP N/A
  • Revenue
  • FGEN $7,346,000.00
  • XBP $148,332,000.00
  • Revenue This Year
  • FGEN N/A
  • XBP N/A
  • Revenue Next Year
  • FGEN N/A
  • XBP N/A
  • P/E Ratio
  • FGEN N/A
  • XBP N/A
  • Revenue Growth
  • FGEN N/A
  • XBP 0.23
  • 52 Week Low
  • FGEN $4.50
  • XBP $0.42
  • 52 Week High
  • FGEN $21.94
  • XBP $2.56
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 59.74
  • XBP 67.40
  • Support Level
  • FGEN $11.12
  • XBP $0.65
  • Resistance Level
  • FGEN $12.53
  • XBP $1.01
  • Average True Range (ATR)
  • FGEN 0.87
  • XBP 0.10
  • MACD
  • FGEN -0.07
  • XBP 0.05
  • Stochastic Oscillator
  • FGEN 66.81
  • XBP 93.13

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About XBP XBP Europe Holdings Inc.

XBP Global Holdings Inc is a multinational leader in business process automation, serving over 2,500 clients-including more than 30 Fortune 100 companies. Its proprietary software and deep domain expertise position it as a trusted technology and services partner. With cloud-based solutions and a global footprint, XBP Global delivers measurable value, improves advances digital transformation, improves market-wide liquidity by expediting payments, and promotes sustainable business practices.

Share on Social Networks: